Target Name: ZFP30
NCBI ID: G22835
Review Report on ZFP30 Target / Biomarker Content of Review Report on ZFP30 Target / Biomarker
ZFP30
Other Name(s): ZFP30_HUMAN | Zfp-30 | KIAA0961 | Zinc finger protein 745 | Zinc finger protein 30 homolog (isoform 1) | ZFP30 zinc finger protein | ZNF745 | ZFP30 zinc finger protein, transcript variant 1 | Zinc finger protein 30 homolog | zinc finger protein 745 | ZFP30 variant 1

The ZFP30 Gene: Potential Drug Targets for Various Diseases

ZFP30 (ZFP30_HUMAN), a gene that encodes for a protein known as ZFP30, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZFP30 is a member of the Zinc Finger Protein ( ZFP) family, which is characterized by the presence of a Zn2+-dependent zinc finger domain and a variable number of additional domains, such as a is due to conserved structure, function and subdomains. Variations in the ZFP30 gene are closely related to the occurrence and development of a variety of diseases, so it is considered a very attractive drug target.

Variations in the ZFP30 gene are associated with many diseases. For example, variations in the ZFP30 gene are closely associated with cancer progression and treatment response. Many studies have shown that variations in the ZFP30 gene are positively correlated with the ability of invasion, growth and spread of various cancers. In addition, mutations in the ZFP30 gene are also closely related to tumor immune evasion. Immune escape means that tumor cells resist killing by immune cells in various ways, resulting in tumor resistance to immunotherapy. Therefore, intervention against mutations in the ZFP30 gene is expected to provide new ideas and strategies for cancer treatment.

Variations in the ZFP30 gene are also closely related to neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. These diseases often cause symptoms such as cognitive decline, behavioral abnormalities, and muscle stiffness, seriously affecting patients' quality of life and health status. Research has found that variations in the ZFP30 gene are closely related to the occurrence and development of neurodegenerative diseases. By targeting mutations in the ZFP30 gene, it is expected to provide new treatments and drug targets for these diseases.

Variations in the ZFP30 gene are also closely related to immunology-related diseases, such as autoimmune diseases, inflammatory bowel disease, and autoimmune diseases. These diseases often cause the immune system to overreact, leading to inflammation, damage, and disease. Studies have found that variations in the ZFP30 gene are closely related to the onset and development of immunologically related diseases. By targeting mutations in the ZFP30 gene, it is expected to provide new treatments and drug targets for these diseases.

Variations in the ZFP30 gene are also closely related to drug resistance and tumor recurrence. Drug resistance refers to the resistance of tumor cells to drugs, resulting in the failure of drug treatment. Tumor recurrence refers to the reappearance of tumor cells during or after treatment, which seriously affects the treatment effect and survival rate of patients. Studies have found that variations in the ZFP30 gene are closely related to drug resistance and tumor recurrence. Intervening against mutations in the ZFP30 gene is expected to provide new treatment methods and drug targets for drug resistance and tumor recurrence.

Variations in the ZFP30 gene are also closely related to the growth and spread of tumor cells. The growth and spread of tumor cells refers to the spread and growth of tumor cells in the body, leading to tumor invasion and metastasis. Studies have found that variations in the ZFP30 gene are closely related to the growth and spread of tumor cells. By targeting mutations in the ZFP30 gene, it is expected to provide new treatments and drug targets for the growth and spread of tumor cells.

Variations in the ZFP30 gene are also closely related to tumor immune evasion. Tumor immune evasion means that tumor cells resist killing by immune cells in various ways, resulting in tumor resistance to immunotherapy. Studies have found that mutations in the ZFP30 gene are closely related to tumor immune evasion. Intervening against mutations in the ZFP30 gene is expected to provide new ideas and strategies for tumor treatment.

Variations in the ZFP30 gene are also closely related to the structure and function of neurons. Neurons are the basic units of the nervous system, and their structure and function are crucial to the normal functioning of the nervous system. Research has found that variations in the ZFP30 gene are closely related to the structure and function of neurons. By targeting mutations in the ZFP30 gene, it is expected to provide new protection and improvement for the health and function of the nervous system.

Variations in the ZFP30 gene are also related to immune cell

Protein Name: ZFP30 Zinc Finger Protein

Functions: May be involved in transcriptional regulation

The "ZFP30 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFP30 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZFP36 | ZFP36L1 | ZFP36L2 | ZFP37 | ZFP41 | ZFP42 | ZFP57 | ZFP62 | ZFP64 | ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90 | ZFP91 | ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134